CFO appointment
Mondelēz International, Inc. appoints Amit Banati as CFO
Mondelēz International, Inc. reported in a Form 8-K filed June 18, 2026 that Amit Banati was appointed Executive Vice President and Chief Financial Officer, effective July 1, 2026.
In the filing's words
On June 15, 2026, Mondelēz International, Inc. (the “Company”) announced the appointment of Amit Banati as Executive Vice President and Chief Financial Officer, effective July 1, 2026 (the “Start Date”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Mondelēz International, Inc. (MDLZ) |
|---|---|
| Event | Appointment |
| Incoming | Amit Banati |
| Title in the filing | Executive Vice President and Chief Financial Officer |
| Effective | July 1, 2026 |
| 8-K filed | June 18, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Chief Financial Officer, Kenvue, Inc |
| SEC CIK | 0001103982 |
Mondelēz International, Inc. reported this change in a Form 8-K, Item 5.02, filed June 18, 2026. The filing's own words are quoted above.
Other records naming Amit Banati
2The incoming officer on this record, matched by name. Career line.
7 months ago· 2026-04-15InterimKVUE
Kenvue Inc. names Heather Howlett interim CFO
2026-02-20 · 10-K signature
Amit Banati signed Kenvue Inc.'s annual report as Chief Financial Officer (Principal Financial Officer)
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Amit Banati? Send a correction with the primary source.